The EGFR mutation in non-small cell lung cancer (NSCLC) was first identified in 2004, and the major missense and deletion mutation of EGFR in NSCLC occurs in the tyrosine kinase-coding domain in exons 18–21 (28). This evidence concerns the gene EGFR and non-small cell lung carcinoma.